Clinical trial Recruiting at 1 site Observational Ages 19 and up

Predicting recovery after knee replacement using smart insoles and AI

Official title: Prediction of Patient-reported Outcome Measure and Performance-based Measure After Total Knee Arthroplasty Using Instrumented Insoles and Deep Neural Networks

Run by Yonsei University · NCT07367789 · Data updated 2026-11-12

This study will test whether preoperative clinical information and walking data from instrumented insoles can help predict recovery six weeks after total knee replacement for adults with knee osteoarthritis.

Quick facts

Study typeObservational
Ages19 Years and up
SexAll
Enrollment200 (estimated)
SponsorYonsei University
Academic / other
Locations1 site (Yongin-si, Gyeonggi-do)
StatusRecruiting
StartedJune 1, 2021
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJanuary 26, 2026
Trial IDNCT07367789 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 19 or older with radiographic knee osteoarthritis scheduled for primary total knee arthroplasty who can walk independently (FAC ≥ 3) at the participating hospitals are ideal candidates.

Probably not a fit

Patients who are non-ambulatory, have a prior TKA on the same knee, have neurological or musculoskeletal disorders that affect gait, are pregnant, or cancel their surgery are unlikely to benefit from the predictive models.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter prospective observational study will collect preoperative demographic data, body composition, muscle strength, comorbidity profiles, Kellgren-Lawrence radiographic grade, and gait data from instrumented insoles during the Timed Up and Go Test. Participants will complete validated patient-reported outcome measures (WOMAC) and performance-based mobility tests before surgery and at six weeks after surgery. Prediction models including linear regression, random forest, and deep neural networks will be trained using the same input variables and compared using accuracy and ROC-AUC. The protocol involves only gait assessments and questionnaires and is expected to pose minimal additional risk.

Why it matters

Potential benefit: If successful, the approach could provide individualized predictions of short-term improvement after TKA to help guide patient expectations and rehabilitation planning.

How similar studies have gone: Previous work using wearable sensors and machine-learning has shown promise for predicting mobility and patient-reported outcomes, but combining instrumented insoles with deep neural networks specifically for TKA recovery is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 19 years
* Diagnosed with knee osteoarthritis (Kellgren-Lawrence grade 1-4)
* Scheduled for primary Total Knee Arthroplasty (TKA) at either study site
* Able to walk independently on level ground (Functional Ambulation Categories, FAC ≥ 3)

Exclusion Criteria:

* Cancellation of scheduled TKA
* History of TKA on the same knee
* Neurological or musculoskeletal disorders affecting gait
* Pregnancy or possibility of pregnancy
* Any condition deemed inappropriate for study participation by the investigator

Where it's running

  • Yongin Severance Hospital
    Yongin-si, Gyeonggi-do, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.